Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-25 | 7,583.47 | 2,074.54 | 127.59p | 25.7 | 2.6 | +10% | 50.81p | 0.0% |
31-Mar-26 | 8,128.30 | 2,282.27 | 141.94p | 23.1 | 2.1 | +11% | 55.38p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
31-Mar-2025 | 7,584 | 7,579 | 7,560 | 7,566 | 7,548 | 7,540 |
31-Mar-2026 | 8,128 | 8,113 | 8,081 | 8,132 | 8,059 | n/a |
Earnings | ||||||
31-Mar-2025 | 127.59p | 128.70p | 126.05p | 127.04p | 130.77p | 195.72p |
31-Mar-2026 | 141.94p | 142.85p | 138.92p | 138.86p | 143.78p | n/a |
Dividend | ||||||
31-Mar-2025 | 50.81p | 51.35p | 50.24p | 50.16p | 52.26p | 87.18p |
31-Mar-2026 | 55.38p | 55.76p | 54.37p | 54.19p | 56.75p | n/a |
Recommendations | ||||||
Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
Buy | 9 | 8 | 8 | 7 | 5 | 7 |
Neutral | 3 | 3 | 2 | 4 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 1 | 0 |
No. of Brokers | 17 | 16 | 15 | 15 | 15 | 16 |
Average Rec | 7.35 | 7.34 | 7.50 | 7.00 | 6.33 | 6.88 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 3,277.00p |
Change Today | 21.00p |
% Change | 0.65 % |
52 Week High | 3,502.00 |
52 Week Low | 2,390.00 |
Volume | 887,105 |
Shares Issued | 918.18m |
Market Cap | £30,089m |
RiskGrade | 148 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 9 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 17 |
Latest | Previous | |
---|---|---|
1st Interim | 2nd Interim | |
Ex-Div | 04-Jan-24 | 22-Jun-23 |
Paid | 02-Feb-24 | 21-Jul-23 |
Amount | 18.00¢ | 37.75¢ |
Time | Volume / Share Price |
15:11 | 1 @ 3,290.00p |
15:03 | 0 @ 3,296.00p |
16:49 | 911 @ 3,277.00p |
16:35 | 424,493 @ 3,277.00p |
16:35 | 486 @ 3,277.00p |
CEO | Brian Cassin |
CFO | Lloyd Pitchford |
Chair | Mike Rogers |
You are here: research